Current status and challenges of immunotherapy in hepatocellular carcinomaQU Jian-hui, ZHANG Cui-hong, LI Ruo-ran, LU Yin-ying193-197,208
Consensus and controversy in surgical treatment for colorectal cancer with liver metastasisAN Song-lin, DING lei, GAO Hong, WU Jian-xiong198-202
Efficacy and safety of stereotactic body radiation therapy for hepatocellular carcinomaCHENG Shu-hui, WANG Wei-hu203-208
The influence and alteration of EpCAM expression in TACE treated hepatocellular carcinomaLOU Min, BAI Wen-Lin, CHANG Xiu-juan, LIU Ze, LI YIN-yin, RONG Guang-hua, ZENG Zhen209-212,221
Peripheral NK cell frequency function and receptor expression in patients with hepatocellular carcinomaZHANG Ai-min, LIU Fang-fang, YANG Xiao, LI Wen-gang, HAN Ping, LIU Li-ying, DUAN Xue-zhang213-215,227
Association between KIR genes polymorphisms and the efficacy of entecavir treatment in patients with chronic hepatitis BSUN Di, YANG Jian, LIU Xiang-zhong, ZHAO Shou-guang, SONG Zhe, HU Ke-yi, XU Ming-hua, SU Jie, LIU Jin-ling, ZHUANG Yun-long216-221
Clinical comparison of stereotactic body radiotherapy and radiofrequency ablation in the treatment of liver cancerZHANG Tao, XIE Hui, SUN Jing, HE Wei-ping, LI Huan, XUE Hui, XU Hui-jun, WANG Hua-ming, DUAN Xue-zhang222-227
Efficacy of stereotactic radiotherapy for patients with primary hepatocellular carcinoma and portal vein tumor thrombosisXUE Hui, LIU Hu, HAN ping, ZHANG Ai-min, LI Wen-gang, LIU Li-ying, DUAN Xue-zhang228-232
Clinical characteristics of primary liver cancer in 27 childrenXU Zhi-qiang, ZHU Shi-shu, ZHANG Hong-fei, DONG Yi, CHEN Da-wei, GAN Yu, WANG Li-min, WANG Fu-chuan, CAO Li-li, ZHANG Min233-235,252
Advances in animal models of HBV infection and replicationYANG Yue, XU Zhi-hui, LIU Yan, XU Dong-ping236-241